NIH-funded research R01 grant

Cholinergic signals and thinking in Lewy body dementia

Official title: Cholinergic Mechanisms in Lewy Body Dementia

Funded at University of Florida · NIH-11579866 · Data updated 2026-11-12

This grant explores how acetylcholine signaling in a specific brain region affects thinking and memory in Lewy body dementia and related conditions.

More Dementia research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Florida
NIH-funded
Lab location1 site (Gainesville, United States)
Project startApril 1, 2023
Project endMarch 31, 2028
Funding year2026
Award (this year)$64,923
NIH project number3R01NS132293-04S1
Project IDNIH-11579866 on NIH RePORTER

Who could benefit from this research

Could help

Patients with Lewy body dementia, Parkinson’s disease dementia, or Alzheimer’s disease with concurrent α-synuclein pathology may indirectly benefit from advances arising from this research.

Less likely to help

People without dementias or without involvement of α-synuclein–related pathology are unlikely to benefit from this project.

What this research studies

The research asks how loss of cholinergic neurons in the basal forebrain and its influence on the prelimbic medial prefrontal cortex contributes to cognitive problems seen in Lewy body dementias and Alzheimer’s disease. It focuses on the M1 receptors and how acetylcholine modulates the brain circuits that support executive function. The team plans to use existing animal models and human-relevant approaches to study these neural pathways and test potential mechanisms behind cognitive decline. This work aims to map targets for therapies that could preserve or improve thinking skills for people living with these conditions.

Why it matters

Potential benefit: Understanding these mechanisms could lead to new strategies to protect or restore cognitive function in patients with Lewy body dementia and related disorders.

How similar studies have gone: Emerging research supports a role for acetylcholine and M1 receptors in executive function; this study builds on those findings in dementia contexts.

Where this research is happening

  • University of Florida
    Gainesville, United States
    Active

Researchers

  • Principal investigator: Moehle, Mark S — University of Florida
  • Study coordinator: Moehle, Mark S

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.